Based on the FY 2010 appropriation, the National Institute on Drug Abuse (NIDA) has established the following funding policy for non-ARRA related projects.
NIDA will continue to support the:
Competing
The FY 2010 average cost of competing grants is allowed to increase by 2% over FY 2009.
Non-Competing Continuations (Type 5)
-
All non-competing continuations (modular and non-modular) will be funded at 99% of committed levels, including co-funds. This policy does not apply to F's, T's, K's, SBIR/STTR and R13s. Future commitments will be adjusted accordingly.
-
Information regarding the NIH Fiscal Policy for Grant Awards - FY 2010 can be found at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-10-039.html
New and Early Stage Investigators
Ruth L. Kirschstein National Research Service Awards (NRSA)
-
NIDA will support a 1% increase at all stipend levels